Trajan strengthens their health business with appointment of Marco Baccanti

Trajan strengthens their health business with appointment of Marco Baccanti

July 18, 2019

Adelaide, South Australia, Australia

Trajan Scientific and Medical (Trajan) has appointed Marco Baccanti as CEO of its joint venture (JV) in nutritional testing, Trajan Nutrition. Mr. Baccanti’s appointment strengthens Trajan Nutrition to accelerate the growth and impact of the work and research led by Trajan and professors Maria Makrides and Robert Gibson.

Mr. Stephen Tomisich (CEO Trajan) said, “We are incredibly fortunate to have someone of Marco’s experience and seniority join the Trajan team.”

After his previous appointments in leadership positions in the science industry and research institutions in Italy, and in the government of the UAE, Mr. Baccanti was most recently the Chief Executive at Health Industries, Government of South Australia, where he was responsible for economic development in the life sciences sector. During his 4-year tenure, his organization achieved the establishment of 23 companies with over 600 new direct jobs, clinical research investments from 10 overseas biotech companies and numerous university-industry collaborations.

“Mr. Baccanti’s background and connection to the healthcare sector in Australia is ideal to accelerate our progress with Trajan Nutrition, and more broadly, adoption of Trajan’s microsampling technologies.” said Mr. Tomisich.

Mr. Tomisich highlights, “Beyond the role in leading Trajan Nutrition we see Marco as potentially leading further collaboration between Trajan, state and federal governments, universities and the healthcare sector in Australia.”

Trajan continues to drive disruption in the healthcare sector worldwide; promoting decentralization of healthcare by developing and bringing to market microsampling technologies.

Mr. Baccanti comments, “I feel very enthusiastic to join an industrial group that is experiencing such a fast, global expansion, with a clear vision to contribute and serve the evolution of global healthcare towards a more sustainable, patient-centric and delocalized approach, with a stronger focus on prevention and wellness.”

“I am totally aligned to this vision, that has been a leitmotiv in all my previous roles, in Europe, the Middle East and in Australia, and I see now this new mandate as an ideal continuation of what I have been learning and doing in my last 25 years in industry, governments and research institutions.” said Mr Baccanti.

Trajan enriches the wellbeing of a growing number of communities through improved scientific and medical tools and technologies. They have completed 7 acquisitions over 6 years, increased their workforce to over 450 staff and continue to develop partnerships with unique collaboration models with academia, industry experts and likeminded organizations.

Trajan Scientific and Medical CEO Stephen Tomisich, and Trajan Nutrition CEO Marco Baccanti
Photo(L-R): Trajan Scientific and Medical CEO Stephen Tomisich, and Trajan Nutrition CEO Marco Baccanti.

Download
Press release [PDF]

More information
www.trajannutrition.com

Media contact information
Trajan Scientific and Medical
Tel: +44 (0) 1908 568 844
media@trajanscimed.com




Also in News

Trajan completes ISO 9001 recertification
Trajan completes ISO 9001 recertification

July 14, 2021

Trajan Scientific and Medical has successfully completed a 3-year ISO 9001:2015 recertification at our Ringwood global headquarters this week, cementing the importance that we place over quality management and continuous improvement for ourselves and all stakeholders.

Read More

Global analytical science and device company Trajan Group announces IPO and $50M capital injection to fuel next phase of growth
Global analytical science and device company Trajan Group announces IPO and $50M capital injection to fuel next phase of growth

May 17, 2021

Global analytical science and device company Trajan Group Holdings Limited (Trajan or the Company) has launched a $90 million IPO to support the next phase of accelerated growth.

Read More

Trajan acquires personalised blood testing business to strengthen move into data-based preventative healthcare
Trajan acquires personalised blood testing business to strengthen move into data-based preventative healthcare

April 16, 2021

Trajan Scientific and Medical (Trajan) has completed the acquisition of the MyHealthTest blood testing service for an undisclosed sum. The acquisition further boosts Trajan’s ability to deliver analytical measurement services to society at a time when preventative healthcare strategies are becoming increasingly important.

Read More